Show simple item record

dc.contributor.authorStylianou, Spyros
dc.contributor.authorClarke, Robert B
dc.contributor.authorBrennan, Keith
dc.date.accessioned2009-07-07T12:02:49Z
dc.date.available2009-07-07T12:02:49Z
dc.date.issued2006-02-01
dc.identifier.citationAberrant activation of notch signaling in human breast cancer. 2006, 66 (3):1517-25 Cancer Res.en
dc.identifier.issn0008-5472
dc.identifier.pmid16452208
dc.identifier.doi10.1158/0008-5472.CAN-05-3054
dc.identifier.urihttp://hdl.handle.net/10541/72749
dc.description.abstractA role for Notch signaling in human breast cancer has been suggested by both the development of adenocarcinomas in the murine mammary gland following pathway activation and the loss of Numb expression, a negative regulator of the Notch pathway, in a large proportion of breast carcinomas. However, it is not clear currently whether Notch signaling is frequently activated in breast tumors, and how it causes cellular transformation. Here, we show accumulation of the intracellular domain of Notch1 and hence increased Notch signaling in a wide variety of human breast carcinomas. In addition, we show that increased RBP-Jkappa-dependent Notch signaling is sufficient to transform normal breast epithelial cells and that the mechanism of transformation is most likely through the suppression of apoptosis. More significantly, we show that attenuation of Notch signaling reverts the transformed phenotype of human breast cancer cell lines, suggesting that inhibition of Notch signaling may be a therapeutic strategy for this disease.
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectCell Line Tumouren
dc.subject.meshApoptosis
dc.subject.meshBreast Neoplasms
dc.subject.meshCell Line, Tumor
dc.subject.meshCell Transformation, Neoplastic
dc.subject.meshEpithelial Cells
dc.subject.meshHumans
dc.subject.meshReceptor, Notch1
dc.subject.meshReceptors, Notch
dc.subject.meshSignal Transduction
dc.titleAberrant activation of notch signaling in human breast cancer.en
dc.typeArticleen
dc.contributor.departmentWellcome Trust Centre for Cell Matrix Research, Faculty of Life Sciences, University of Manchester, Christie Hospital NHS Trust, Manchester M13 9PT, United Kingdom.en
dc.identifier.journalCancer Researchen
html.description.abstractA role for Notch signaling in human breast cancer has been suggested by both the development of adenocarcinomas in the murine mammary gland following pathway activation and the loss of Numb expression, a negative regulator of the Notch pathway, in a large proportion of breast carcinomas. However, it is not clear currently whether Notch signaling is frequently activated in breast tumors, and how it causes cellular transformation. Here, we show accumulation of the intracellular domain of Notch1 and hence increased Notch signaling in a wide variety of human breast carcinomas. In addition, we show that increased RBP-Jkappa-dependent Notch signaling is sufficient to transform normal breast epithelial cells and that the mechanism of transformation is most likely through the suppression of apoptosis. More significantly, we show that attenuation of Notch signaling reverts the transformed phenotype of human breast cancer cell lines, suggesting that inhibition of Notch signaling may be a therapeutic strategy for this disease.


This item appears in the following Collection(s)

Show simple item record